DexCom, Inc. (DXCM)
Company Info
Highlights
$30.39B
$1.65
47.15
1.19
$3.95B
$2.44B
$975.30M
$62.34 - $142.00
$96.10
2.44%
2.11
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in DexCom, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
DexCom, Inc. had a return of -35.50% year-to-date (YTD) and -34.82% in the last 12 months. Over the past 10 years, DexCom, Inc. had an annualized return of 19.53%, outperforming the S&P 500 benchmark which had an annualized return of 11.06%.
DXCM
-35.50%
6.38%
-31.38%
-34.82%
8.46%
19.53%
^GSPC (Benchmark)
24.34%
0.23%
8.53%
24.95%
13.01%
11.06%
Monthly Returns
The table below presents the monthly returns of DXCM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.21% | -5.18% | 20.54% | -8.15% | -6.77% | -4.54% | -40.18% | 2.24% | -3.32% | 5.13% | 10.66% | -35.50% | |
| 2023 | -5.43% | 3.66% | 4.66% | 4.44% | -3.36% | 9.59% | -3.07% | -18.93% | -7.61% | -4.79% | 30.05% | 7.42% | 9.58% |
| 2022 | -19.83% | -3.85% | 23.60% | -20.14% | -27.08% | 0.06% | 10.13% | 0.16% | -2.03% | 49.96% | -3.73% | -2.61% | -15.64% |
| 2021 | 1.39% | 6.12% | -9.65% | 7.43% | -4.33% | 15.60% | 20.73% | 2.70% | 3.29% | 13.96% | -9.73% | -4.56% | 45.23% |
| 2020 | 10.06% | 14.64% | -2.44% | 24.48% | 12.86% | 7.16% | 7.43% | -2.33% | -3.10% | -22.48% | 0.03% | 15.65% | 69.02% |
| 2019 | 17.72% | -1.21% | -14.52% | 1.65% | 0.19% | 23.53% | 4.69% | 9.40% | -13.04% | 3.35% | 47.37% | -3.77% | 82.59% |
| 2018 | 1.41% | -3.54% | 32.10% | -1.32% | 20.24% | 7.94% | 0.16% | 51.77% | -0.93% | -7.18% | -2.40% | -7.55% | 108.75% |
| 2017 | 32.58% | -1.25% | 8.41% | -7.99% | -14.26% | 9.44% | -8.94% | 12.01% | -34.42% | -8.09% | 29.93% | -1.78% | -3.87% |
| 2016 | -12.97% | -8.73% | 4.38% | -5.20% | 0.17% | 23.01% | 16.26% | -1.24% | -3.77% | -10.75% | -16.55% | -8.56% | -27.11% |
| 2015 | 8.59% | 1.61% | 2.63% | 8.39% | 6.14% | 11.52% | 5.84% | 11.21% | -8.80% | -2.96% | 2.04% | -3.67% | 48.77% |
| 2014 | 14.26% | 11.47% | -8.29% | -21.57% | 4.07% | 17.48% | -4.99% | 17.30% | -9.52% | 12.40% | 14.48% | 6.98% | 55.46% |
| 2013 | 12.07% | -2.04% | 12.06% | -1.85% | 26.93% | 7.78% | -2.98% | 24.20% | 4.33% | 1.81% | 15.18% | 7.01% | 160.56% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of DXCM is 22, meaning it’s performing worse than 78% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for DexCom, Inc. (DXCM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the DexCom, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the DexCom, Inc. was 94.61%, occurring on Nov 20, 2008. Recovery took 1185 trading sessions.
The current DexCom, Inc. drawdown is 50.84%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.61% | May 5, 2006 | 643 | Nov 20, 2008 | 1185 | Aug 8, 2013 | 1828 |
| -60.69% | Nov 18, 2021 | 674 | Jul 26, 2024 | — | — | — |
| -56.37% | Sep 18, 2015 | 532 | Oct 26, 2017 | 176 | Jul 11, 2018 | 708 |
| -39.59% | Mar 6, 2014 | 44 | May 7, 2014 | 129 | Nov 7, 2014 | 173 |
| -36.81% | Feb 21, 2020 | 19 | Mar 18, 2020 | 20 | Apr 16, 2020 | 39 |
Volatility
Volatility Chart
The current DexCom, Inc. volatility is 11.34%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of DexCom, Inc. compared to its peers in the Diagnostics & Research industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for DXCM in comparison to other companies of the Diagnostics & Research industry. Currently, DXCM has a PE value of 47.2. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for DXCM in comparison to other companies of the Diagnostics & Research industry. Currently, DXCM has a PEG value of 1.2. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for DexCom, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |